Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuejun Zhang

Showing results (581-590 of 600) with videos related to

Pageof 60
Sort By:
Annals of the Rheumatic Diseases|December 14, 2017
Exome-wide association study identifies four novel loci for systemic lupus erythematosus in Han Chinese populationLeilei Wen, Caihong Zhu, Zhengwei Zhu, et al.
Global Change Biology|April 14, 2020
Plastic pollution in croplands threatens long-term food securityDan Zhang, Ee Ling Ng, Wanli Hu, et al.
American Journal of Human Genetics|June 7, 2011
Genetic variants at 13q12.12 are associated with high myopia in the Han Chinese populationYi Shi, Jia Qu, Dingding Zhang, et al.
Nature Communications|April 24, 2015
Genome-wide meta-analysis identifies multiple novel associations and ethnic heterogeneity of psoriasis susceptibilityXianyong Yin, Hui Qi Low, Ling Wang, et al.
The Journal of Investigative Dermatology|October 18, 2020
Exome-Wide Association Analysis Suggests LRP2BP as a Susceptibility Gene for Endothelial Injury in Systemic Sclerosis in the Han Chinese PopulationWeilin Pu, Wenyu Wu, Qingmei Liu, et al.
Nature Communications|March 14, 2018
Author Correction: Whole-exome SNP array identifies 15 new susceptibility loci for psoriasisXianbo Zuo, Liangdan Sun, Xianyong Yin, et al.
Nature Communications|April 10, 2015
Whole-exome SNP array identifies 15 new susceptibility loci for psoriasisXianbo Zuo, Liangdan Sun, Xianyong Yin, et al.
BMC Cancer|October 14, 2023
Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trialZhongjun Xia, Yun Leng, Baijun Fang, et al.
Nature|October 26, 2022
Neoadjuvant relatlimab and nivolumab in resectable melanomaRodabe N Amaria, Michael Postow, Elizabeth M Burton, et al.
Nature Genetics|June 4, 2013
High-density genotyping study identifies four new susceptibility loci for atopic dermatitisDavid Ellinghaus, Hansjörg Baurecht, Jorge Esparza-Gordillo, et al.
Pageof 60

Showing results (581-590 of 600) with videos related to

Sort By:
Pageof 60
Annals of the Rheumatic Diseases|December 14, 2017
Exome-wide association study identifies four novel loci for systemic lupus erythematosus in Han Chinese populationLeilei Wen, Caihong Zhu, Zhengwei Zhu, et al.
Global Change Biology|April 14, 2020
Plastic pollution in croplands threatens long-term food securityDan Zhang, Ee Ling Ng, Wanli Hu, et al.
American Journal of Human Genetics|June 7, 2011
Genetic variants at 13q12.12 are associated with high myopia in the Han Chinese populationYi Shi, Jia Qu, Dingding Zhang, et al.
Nature Communications|April 24, 2015
Genome-wide meta-analysis identifies multiple novel associations and ethnic heterogeneity of psoriasis susceptibilityXianyong Yin, Hui Qi Low, Ling Wang, et al.
The Journal of Investigative Dermatology|October 18, 2020
Exome-Wide Association Analysis Suggests LRP2BP as a Susceptibility Gene for Endothelial Injury in Systemic Sclerosis in the Han Chinese PopulationWeilin Pu, Wenyu Wu, Qingmei Liu, et al.
Nature Communications|March 14, 2018
Author Correction: Whole-exome SNP array identifies 15 new susceptibility loci for psoriasisXianbo Zuo, Liangdan Sun, Xianyong Yin, et al.
Nature Communications|April 10, 2015
Whole-exome SNP array identifies 15 new susceptibility loci for psoriasisXianbo Zuo, Liangdan Sun, Xianyong Yin, et al.
BMC Cancer|October 14, 2023
Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trialZhongjun Xia, Yun Leng, Baijun Fang, et al.
Nature|October 26, 2022
Neoadjuvant relatlimab and nivolumab in resectable melanomaRodabe N Amaria, Michael Postow, Elizabeth M Burton, et al.
Nature Genetics|June 4, 2013
High-density genotyping study identifies four new susceptibility loci for atopic dermatitisDavid Ellinghaus, Hansjörg Baurecht, Jorge Esparza-Gordillo, et al.
Pageof 60